IDDF2018-ABS-0058 Early normalisation of alanine aminotransferase (alt) after nucleos(t)ide analogue treatment reduces the risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b – a territory-wide study of 21,182 subjects